Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities.
Saved in:
| Title: | Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities. |
|---|---|
| Authors: | Stacchiotti S; Department of Medical Oncology, National Cancer Institute of Milan, Milan, Italy., Frezza AM; Department of Medical Oncology, National Cancer Institute of Milan, Milan, Italy., Blay JY; Leon Berard Center, Claude Bernard University Lyon 1, UNICANCER Hospital Network, Lyon, France., Baldini EH; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts., Bonvalot S; Department of Surgical Oncology, Curie Institute, University of Paris-Sciences and Letters, Paris, France., Bovée JVMG; Department of Pathology, Leiden University Medical Center, Leiden, Netherlands., Callegaro D; Department of Surgery, National Cancer Institute of Milan, Milan, Italy., Casali PG; Department of Medical Oncology, National Cancer Institute of Milan, Milan, Italy., Chiang RC; Taiwan Cancer Registry Center, Taipei, Taiwan.; Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan., Demetri GD; Department of Medical Oncology, Ludwig Center at Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts., Demicco EG; Department of Pathobiology and Laboratory Medicine, University of Toronto/Mount Sinai Hospital, Toronto, Ontario, Canada., Desai J; Department of Medical Oncology, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia., Eriksson M; Department of Oncology, Skane University Hospital and Lund University, Lund, Sweden., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands., George S; Department of Medical Oncology, Ludwig Center at Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts., Gounder MM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York., Gronchi A; Department of Surgery, National Cancer Institute of Milan, Milan, Italy., Gupta A; Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.; Princess Margaret Cancer Center, Toronto, Ontario, Canada., Haas RL; Department of Radiotherapy, Netherlands Cancer Institute, Amsterdam, Netherlands.; Department of Radiotherapy, Leiden University Medical Center, Amsterdam, Netherlands., Hayes-Jardon A; Department of Surgery, the Royal Marsden National Health Service Foundation Trust, London, United Kingdom., Hohenberger P; Sarcoma Unit, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany., Jones KB; Department of Orthopedics, University of Utah, Salt Lake City, Utah., Jones RL; Sarcoma Unit, Royal Marsden NHS Foundation Trust/Institute of Cancer Research, London, UK., Kasper B; Sarcoma Unit, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany., Kawai A; Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan., Kirsch DG; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina., Kleinerman ES; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Le Cesne A; Medical Oncology, Gustave Roussy Institute, Villejuif, Ile-de-France, France., Lim J; Division of Cancer Registration and Surveillance, National Cancer Center, Ilsandong-gu, Goyang-si, Republic of Korea., Chirlaque López MD; Department of Epidemiology, Regional Health Council, Biomedical Research Institute of Murcia-Arrixaca, Murcia University, Murcia, Spain., Maestro R; Unit of Oncogenetics and Functional Oncogenomics, Aviano IRCCS Oncology Referral Center, Aviano, Italy., Marcos-Gragera R; Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Girona, Spain., Martin Broto J; Medical Oncology Department, University Hospital Virgen del Rocio, Sevilla, Spain., Matsuda T; National Cancer Registry Section, Center for Cancer Registries, Center for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan., Mir O; Medical Oncology, Gustave Roussy Institute, Villejuif, Ile-de-France, France., Patel SR; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Raut CP; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.; Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Razak ARA; Princess Margaret Cancer Center, Toronto, Ontario, Canada., Reed DR; Department of Interdisciplinary Cancer Management, Moffitt Cancer Center, Tampa, Florida., Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Sanfilippo RG; Department of Medical Oncology, National Cancer Institute of Milan, Milan, Italy., Sbaraglia M; Department of Pathology, University Hospital of Padova, Padova, Italy., Schaefer IM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Strauss DC; Sarcoma Unit, Royal Marsden NHS Foundation Trust/Institute of Cancer Research, London, UK., Sundby Hall K; Department of Oncology, the Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Tap WD; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York., Thomas DM; Garvan Institute of Medical Research, Sydney, New South Wales, Australia., van der Graaf WTA; Department of Medical Oncology, Netherlands Cancer Institute Amsterdam, Amsterdam, Netherlands., van Houdt WJ; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Visser O; Department of Registration, Netherlands Comprehensive Cancer Organization, Utrecht, Netherlands., von Mehren M; Department of Hematology and Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Wagner AJ; Department of Medical Oncology, Ludwig Center at Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts., Wilky BA; Department of Medicine, University of Colorado Cancer Center, Aurora, Colorado., Won YJ; Division of Cancer Registration and Surveillance, National Cancer Center, Ilsandong-gu, Goyang-si, Republic of Korea., Fletcher CDM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Dei Tos AP; Department of Pathology, University Hospital of Padova, Padova, Italy., Trama A; Evaluative Epidemiology Unit, Department of Research, National Cancer Institute of Milan, Milan, Italy. |
| Source: | Cancer [Cancer] 2021 Aug 15; Vol. 127 (16), pp. 2934-2942. Date of Electronic Publication: 2021 Apr 28. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Consensus Statement |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1097-0142 |
|---|---|
| DOI: | 10.1002/cncr.33618 |
